Document Detail


Circulating E-selectin as a risk marker in patients with end-stage renal disease.
MedLine Citation:
PMID:  17875185     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: E-selectin is a key adhesion molecule which plays a fundamental role in endothelial progenitor cell-dependent reparative mechanisms in experimental ischaemia and it serves to anchor leucocytes to the endothelium in inflammatory processes. Inflammation is one of the strongest risk factors for death and cardiovascular (CV) events in end-stage renal disease (ESRD). OBJECTIVE: The objective of the current study was to evaluate whether E-selectin is a useful biomarker of clinical outcome in ESRD patients. We tested the prediction power of circulating E-selectin for mortality and CV events in a cohort of 265 ESRD patients. RESULTS: During the follow-up, 59 patients died and 58 had CV events. All-cause mortality was inversely related to serum E-selectin, the risk of death being the lowest in patients in the third E-selectin tertile (HR: 1, reference group), intermediate in those in the second tertile (HR: 1.30) and the highest in patients in the first tertile (HR: 2.02, P = 0.01). Similarly, the risk of fatal and nonfatal CV events followed an inverse pattern being lowest in the third tertile (reference group) and highest in the first tertile (HR: 1.73, P = 0.03). The prediction power of E-selectin for death and CV events was confirmed in a Cox regression analysis where E-selectin emerged as an inverse predictor of these outcomes, particularly so in patients with severe inflammation. CONCLUSIONS: These data are in keeping with the hypothesis that in systemic inflammation altered E-selectin shedding may play a role in arterial damage and implicates this adhesion molecule in atherosclerotic complications in a high-risk condition like ESRD.
Authors:
L S Malatino; B Stancanelli; A Cataliotti; I Bellanuova; P Fatuzzo; F Rapisarda; D Leonardis; G Tripepi; F Mallamaci; C Zoccali
Related Documents :
21764335 - Benign infantile seizures and paroxysmal dyskinesia: a well-defined familial syndrome.
22376135 - Womac-pf as a measure of physical function in patients with parkinson's disease and lat...
19911855 - Valsartan: more than a decade of experience.
9122515 - Body mass index and mortality in patients with severe alpha 1-antitrypsin deficiency.
1813495 - Modification of common low vision devices for uncommon needs.
21353425 - Efficacy of ct-guided biopsies of the spine in patients with spondylitis - an analysis ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of internal medicine     Volume:  262     ISSN:  0954-6820     ISO Abbreviation:  J. Intern. Med.     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-09-18     Completed Date:  2007-11-08     Revised Date:  2008-01-16    
Medline Journal Info:
Nlm Unique ID:  8904841     Medline TA:  J Intern Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  479-87     Citation Subset:  IM    
Affiliation:
Division of Internal Medicine, Department of Medicine and Systemic Disease, Hypertension Centre, University of Catania, Ragusa, Italy. malatino@unict.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / blood
Cardiovascular Diseases / etiology,  mortality*
Cohort Studies
E-Selectin / blood*
Female
Humans
Kidney Failure, Chronic / complications*,  genetics,  mortality
Male
Middle Aged
Prospective Studies
Renal Dialysis / methods
Risk Factors
Chemical
Reg. No./Substance:
0/Biological Markers; 0/E-Selectin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The association between metabolic syndrome, microalbuminuria and impaired renal function in the gene...
Next Document:  Do patient characteristics or factors at resuscitation influence long-term outcome in patients survi...